Jazz Pharmaceuticals plc
JAZZ · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $251 | -$718 | -$93 | $191 |
| Dep. & Amort. | $178 | $174 | $165 | $168 |
| Deferred Tax | -$271 | -$66 | -$44 | -$2 |
| Stock-Based Comp. | $0 | $65 | $68 | $0 |
| Change in WC | $131 | -$327 | $288 | -$80 |
| Other Non-Cash | $186 | $962 | $46 | $121 |
| Operating Cash Flow | $475 | $89 | $430 | $399 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$45 | -$13 | -$14 | -$13 |
| Net Acquisitions | $0 | -$858 | $0 | $0 |
| Inv. Purchases | -$640 | $440 | -$440 | -$470 |
| Inv. Sales/Matur. | $400 | $470 | $310 | $290 |
| Other Inv. Act. | -$43 | -$680 | -$25 | $0 |
| Investing Cash Flow | -$328 | -$641 | -$169 | -$193 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$8 | -$8 | -$758 | -$13 |
| Stock Issued | $1 | $10 | $0 | $9 |
| Stock Repurch. | $0 | -$125 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$4 | -$2 | -$56 | -$4 |
| Financing Cash Flow | -$11 | -$125 | -$813 | -$8 |
| Forex Effect | -$90 | $5 | $2 | $38 |
| Net Chg. in Cash | $46 | -$672 | -$551 | $235 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,190 | $1,862 | $2,413 | $1,968 |
| End Cash | $1,236 | $1,190 | $1,862 | $2,203 |
| Free Cash Flow | $459 | $101 | $391 | $385 |